Adrenal Hyperplasia, Congenital, Due to 21-Hydroxylase Deficiency (AH3)

Adrenal Hyperplasia, Congenital, Due to 21-Hydroxylase Deficiency(来自ICD-11)
别称:
21-Hydroxylase Deficiency
Hyperandrogenism, Nonclassic Type, Due to 21-Hydroxylase Deficiency
Congenital Adrenal Hyperplasia 1
Cah1
Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
Cyp21 Deficiency
Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Hyperandrogenism Nonclassic Type Due to 21-Hydroxylase Deficiency
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficiency
Virilizing Adrenal Hyperplasia
Adrenal Hyperplasia Type Iii
21 Hydroxylase Deficiency
Adrenal Hyperplasia Iii
Adrenal Hyperplasia 3
21-Ohd Cah
Ah-Iii
Ah3
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Adrenal Hyperplasia, Congenital, Due to 21-Hydroxylase Deficiency, also known as 21-hydroxylase deficiency, is related to classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency and lipoid congenital adrenal hyperplasia. An important gene associated with Adrenal Hyperplasia, Congenital, Due to 21-Hydroxylase Deficiency is CYP21A2 (Cytochrome P450 Family 21 Subfamily A Member 2). The drugs Hydrocortisone-17-butyrate and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include adrenal cortex and testes, and related phenotypes are hypertension and fever
查看原文 参与反馈
相关ID:

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
AR
Antenatal
--
2
8
308

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top